tiprankstipranks
Advertisement
Advertisement

LBRX Stock Latest News

LB Pharmaceuticals initiates NOVA-2 trial
The FlyLB Pharmaceuticals initiates NOVA-2 trial
2h ago
LBRX
LB Pharmaceuticals Announces Director Zachary Prensky’s Planned Retirement
PremiumCompany Announcements
LB Pharmaceuticals Announces Director Zachary Prensky’s Planned Retirement
9d ago
8K
LBRX
LB Pharmaceuticals adds neuroscience leader to board, governance
PremiumCompany Announcements
LB Pharmaceuticals adds neuroscience leader to board, governance
15d ago
8K
LBRX
LB Pharmaceuticals appoints Lenz to Board of Directors
PremiumThe Fly
LB Pharmaceuticals appoints Lenz to Board of Directors
16d ago
LBRX
LB Pharmaceuticals management to meet with Piper Sandler
PremiumThe Fly
LB Pharmaceuticals management to meet with Piper Sandler
1M ago
LBRX
LB Pharmaceuticals Announces $100 Million Private Placement Financing
PremiumCompany AnnouncementsLB Pharmaceuticals Announces $100 Million Private Placement Financing
2M ago
8K
LBRX
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
Premium
The Fly
LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement
2M ago
LBRX
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
Premium
Company Announcements
LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia
2M ago
LBRX
LB Pharmaceuticals initiates Phase 2 trial of LB-102
PremiumThe Fly
LB Pharmaceuticals initiates Phase 2 trial of LB-102
2M ago
LBRX
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
PremiumCompany Announcements
LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors
2M ago
LBRX
LB Pharmaceuticals appoints Pazdera as General Counsel
PremiumThe Fly
LB Pharmaceuticals appoints Pazdera as General Counsel
2M ago
LBRX
LB Pharmaceuticals initiated with a Buy at Roth Capital
PremiumThe Fly
LB Pharmaceuticals initiated with a Buy at Roth Capital
3M ago
LBRX
LB Pharmaceuticals appoints Ellen Rose as SVP, corporate affairs
PremiumThe FlyLB Pharmaceuticals appoints Ellen Rose as SVP, corporate affairs
3M ago
LBRX
These 3 Biotech Stocks Can Triple from Current Levels, Say Five-Star Analysts – 12/19/2025
Premium
Market News
These 3 Biotech Stocks Can Triple from Current Levels, Say Five-Star Analysts – 12/19/2025
3M ago
ANAB
LBRX
LB Pharmaceuticals management to meet with Piper Sandler
Premium
The Fly
LB Pharmaceuticals management to meet with Piper Sandler
3M ago
LBRX
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
PremiumThe Fly
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
3M ago
LBRX
LB Pharmaceuticals added to Russell 2000, Russell 3000 indices
PremiumThe Fly
LB Pharmaceuticals added to Russell 2000, Russell 3000 indices
4M ago
LBRX
LB Pharmaceuticals Expands Lease at One Penn Plaza
PremiumCompany Announcements
LB Pharmaceuticals Expands Lease at One Penn Plaza
4M ago
8K
LBRX
LB Pharmaceuticals Appoints New Chief Commercial Officer
PremiumCompany Announcements
LB Pharmaceuticals Appoints New Chief Commercial Officer
4M ago
8K
LBRX
LB Pharmaceuticals appoints Kaya Pai Panandiker as CCO
PremiumThe FlyLB Pharmaceuticals appoints Kaya Pai Panandiker as CCO
4M ago
LBRX
NMRA
LB Pharmaceuticals Reports Strong Q3 and Strategic Progress
Premium
Company Announcements
LB Pharmaceuticals Reports Strong Q3 and Strategic Progress
4M ago
LBRX
LB Pharmaceuticals reports Q3 EPS (61c) vs ($39.49) last year
Premium
The Fly
LB Pharmaceuticals reports Q3 EPS (61c) vs ($39.49) last year
5M ago
LBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >